Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement